Soluble receptor for advanced glycation end-products promotes angiogenesis through activation of STAT3 in myocardial ischemia/reperfusion injury
- 24 April 2020
- journal article
- research article
- Published by Springer Nature in Apoptosis
- Vol. 25 (5-6) , 341-353
Abstract
Soluble receptor for advanced glycation end-products (sRAGE), which exerts cardioprotective effect through inhibiting cardiomyocyte apoptosis and autophagy during ischemia/reperfusion (I/R) injury, is also known to enhance angiogenesis in post-ischemic reperfusion injury-critical limb ischemia (PIRI-CLI) mice. However, whether sRAGE protects the heart from myocardial I/R injury via promoting angiogenesis remains unclear. Myocardial model of I/R injury was conducted by left anterior descending (LAD) ligation for 30 min and reperfusion for 2 weeks in C57BL/6 mice. And I/R injury in cardiac microvascular endothelial cells (CMECs) was duplicated by oxygen and glucose deprivation. The results showed that I/R-induced cardiac dysfunction, inflammation and myocardial fibrosis were all reversed by sRAGE. CD31 immunohistochemistry staining showed that sRAGE increased the density of vessels after I/R injury. The results from cultured CMECs showed that sRAGE inhibited apoptosis and increased proliferation, migration, angiogenesis after exposure to I/R. These effects were dependent on signal transducer and activator of transcription 3 (STAT3) pathway. Together, the present study demonstrated that activation of STAT3 contributed to the protective effects of sRAGE on myocardial I/R injury via promoting angiogenesis.Keywords
Funding Information
- National Natural Science Foundation of China (30801217, 81570321, 81370313, 81870265)
This publication has 30 references indexed in Scilit:
- Reperfusion therapy—What’s with the obstructed, leaky and broken capillaries?Pathophysiology, 2017
- Soluble receptor for advanced glycation end-products protects against ischemia/reperfusion-induced myocardial apoptosis via regulating the ubiquitin proteasome systemFree Radical Biology and Medicine, 2016
- A soluble receptor for advanced glycation end-products inhibits myocardial apoptosis induced by ischemia/reperfusion via the JAK2/STAT3 pathwayApoptosis, 2015
- Alternative splicing of the murine receptor for advanced glycation end‐products (RAGE) geneThe FASEB Journal, 2009
- RAGE and Soluble RAGE: Potential Therapeutic Targets for Cardiovascular DiseasesMolecular Medicine, 2007
- Myocardial Reperfusion InjuryNew England Journal of Medicine, 2007
- VEGF-mediated angiogenesis is impaired by angiotensin type 1 receptor blockade in cardiomyopathic hamster heartsCardiovascular Research, 2003
- Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injuryBiochemical Journal, 2003
- Angiogenesis and the ischaemic heartEuropean Heart Journal, 2001
- Coronary AngiogenesisAnnals of the New York Academy of Sciences, 1995